Inovio Pharmaceuticals Inc. Stock Advances 9.9%, Outperforms Peers
Dow Jones2026/09/30 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. advanced 9.9% to $1.22 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,861.06 and the Dow Jones Industrial Average falling 0.9% to 50,906.05.
The stock's rise snapped a five-day losing streak.
Inovio Pharmaceuticals Inc. closed 55.1% below its 52-week high of $2.72, which the company reached on December 17th.
The stock outperformed some of its peers, as Johnson & Johnson fell 1.1% to $264.74, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.70% to $28.52.
Trading volume totaled 2.6 million, compared to the 50-day average of 4.4 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 30, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Gold: Modest gains in risk-off backdrop – Deutsche Bank
Euro gains against Canadian Dollar ahead of Eurozone HICP data
Major European stock indices open collectively higher
Broadcom (AVGO.US) syndicate begins raising 60 billions USD to supply chip "ammunition" for companies like Anthropic
According to informed sources, Broadcom's Wall Street syndicate is initiating the raising of $60 billion in new financing to purchase artificial intelligence (AI) chips, with beneficiaries including Anthropic PBC and other companies.
Crypto prices
More
